Galmed Pharmaceuticals LTD. (GLMD) — 20-F Filings
All 20-F filings from Galmed Pharmaceuticals LTD.. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.
20-F Filings (2)
-
Galmed Pharmaceuticals Files 2024 Annual Report
— Apr 2, 2025 Risk: medium
Galmed Pharmaceuticals Ltd. filed its annual 20-F report for the fiscal year ending December 31, 2024. The company, incorporated in L3 and headquartered in Rama -
Galmed Pharmaceuticals Ltd. Files 20-F Annual Report
— Apr 4, 2024 Risk: low
Galmed Pharmaceuticals Ltd. (GLMD) filed a Foreign Annual Report (20-F) with the SEC on April 4, 2024. Galmed Pharmaceuticals Ltd. filed its annual report on Fo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX